vs
INSMED Inc（INSM）与RBC Bearings INC（RBC）财务数据对比。点击上方公司名可切换其他公司
RBC Bearings INC的季度营收约是INSMED Inc的1.7倍（$461.6M vs $263.8M），RBC Bearings INC净利率更高（14.6% vs -124.5%，领先139.1%），INSMED Inc同比增速更快（152.6% vs 17.0%），RBC Bearings INC自由现金流更多（$99.1M vs $-264.2M），过去两年INSMED Inc的营收复合增速更高（86.9% vs 5.6%）
Insmed Inc.是一家全球性生物制药公司，专注于为存在高度未满足医疗需求的严重罕见病患者开发、商业化创新疗法，核心布局肺部、内分泌类罕见病治疗赛道，服务覆盖北美、欧洲及亚太地区的患者群体。
该文本实际介绍的并非RBC Bearings，而是美国多佛公司。多佛是一家工业产品综合制造商，1955年成立，总部位于伊利诺伊州当纳斯格罗夫。2021年其业务分为五大板块：工程产品、清洁能源与加注、成像与识别、泵与工艺解决方案、气候与可持续技术，是标普500成分股，在纽约证券交易所上市。
INSM vs RBC — 直观对比
营收规模更大
RBC
是对方的1.7倍
$263.8M
营收增速更快
INSM
高出135.6%
17.0%
净利率更高
RBC
高出139.1%
-124.5%
自由现金流更多
RBC
多$363.3M
$-264.2M
两年增速更快
INSM
近两年复合增速
5.6%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $263.8M | $461.6M |
| 净利润 | $-328.5M | $67.4M |
| 毛利率 | 83.2% | 44.3% |
| 营业利润率 | -121.2% | 22.3% |
| 净利率 | -124.5% | 14.6% |
| 营收同比 | 152.6% | 17.0% |
| 净利润同比 | -39.5% | 16.4% |
| 每股收益（稀释后） | $-1.55 | $2.13 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收INSMRBC
| Q4 25 | $263.8M | $461.6M | ||
| Q3 25 | $142.3M | $455.3M | ||
| Q2 25 | $107.4M | $436.0M | ||
| Q1 25 | $92.8M | $437.7M | ||
| Q4 24 | $104.4M | $394.4M | ||
| Q3 24 | $93.4M | $397.9M | ||
| Q2 24 | $90.3M | $406.3M | ||
| Q1 24 | $75.5M | $413.7M |
净利润INSMRBC
| Q4 25 | $-328.5M | $67.4M | ||
| Q3 25 | $-370.0M | $60.0M | ||
| Q2 25 | $-321.7M | $68.5M | ||
| Q1 25 | $-256.6M | $72.7M | ||
| Q4 24 | $-235.5M | $57.9M | ||
| Q3 24 | $-220.5M | $54.2M | ||
| Q2 24 | $-300.6M | $61.4M | ||
| Q1 24 | $-157.1M | — |
毛利率INSMRBC
| Q4 25 | 83.2% | 44.3% | ||
| Q3 25 | 79.4% | 44.1% | ||
| Q2 25 | 73.9% | 44.8% | ||
| Q1 25 | 77.1% | 44.2% | ||
| Q4 24 | 75.0% | 44.3% | ||
| Q3 24 | 77.3% | 43.7% | ||
| Q2 24 | 76.8% | 45.3% | ||
| Q1 24 | 76.9% | 43.1% |
营业利润率INSMRBC
| Q4 25 | -121.2% | 22.3% | ||
| Q3 25 | -257.1% | 21.5% | ||
| Q2 25 | -291.3% | 23.2% | ||
| Q1 25 | -267.3% | 23.0% | ||
| Q4 24 | -220.6% | 21.7% | ||
| Q3 24 | -228.4% | 21.6% | ||
| Q2 24 | -319.8% | 24.0% | ||
| Q1 24 | -192.7% | 22.8% |
净利率INSMRBC
| Q4 25 | -124.5% | 14.6% | ||
| Q3 25 | -260.0% | 13.2% | ||
| Q2 25 | -299.5% | 15.7% | ||
| Q1 25 | -276.4% | 16.6% | ||
| Q4 24 | -225.5% | 14.7% | ||
| Q3 24 | -236.0% | 13.6% | ||
| Q2 24 | -332.8% | 15.1% | ||
| Q1 24 | -208.1% | — |
每股收益（稀释后）INSMRBC
| Q4 25 | $-1.55 | $2.13 | ||
| Q3 25 | $-1.75 | $1.90 | ||
| Q2 25 | $-1.70 | $2.17 | ||
| Q1 25 | $-1.42 | $2.33 | ||
| Q4 24 | $-1.30 | $1.82 | ||
| Q3 24 | $-1.27 | $1.65 | ||
| Q2 24 | $-1.94 | $1.90 | ||
| Q1 24 | $-1.06 | $1.92 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.4B | $107.6M |
| 总债务越低越好 | $546.8M | $990.2M |
| 股东权益账面价值 | $739.0M | $3.3B |
| 总资产 | $2.3B | $5.1B |
| 负债/权益比越低杠杆越低 | 0.74× | 0.30× |
8季度趋势，按日历期对齐
现金及短期投资INSMRBC
| Q4 25 | $1.4B | $107.6M | ||
| Q3 25 | $1.7B | $91.2M | ||
| Q2 25 | $1.9B | $132.9M | ||
| Q1 25 | $1.2B | $36.8M | ||
| Q4 24 | $1.4B | — | ||
| Q3 24 | $1.5B | — | ||
| Q2 24 | $1.2B | $76.8M | ||
| Q1 24 | $595.7M | $63.5M |
总债务INSMRBC
| Q4 25 | $546.8M | $990.2M | ||
| Q3 25 | $546.8M | $1.1B | ||
| Q2 25 | $546.8M | $915.6M | ||
| Q1 25 | $1.1B | $920.1M | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $971.8M | — | ||
| Q2 24 | $1.2B | — | ||
| Q1 24 | $1.2B | $1.2B |
股东权益INSMRBC
| Q4 25 | $739.0M | $3.3B | ||
| Q3 25 | $945.6M | $3.2B | ||
| Q2 25 | $1.2B | $3.1B | ||
| Q1 25 | $99.2M | $3.0B | ||
| Q4 24 | $285.4M | $2.9B | ||
| Q3 24 | $483.4M | $2.9B | ||
| Q2 24 | $38.8M | $2.8B | ||
| Q1 24 | $-464.8M | $2.8B |
总资产INSMRBC
| Q4 25 | $2.3B | $5.1B | ||
| Q3 25 | $2.4B | $5.1B | ||
| Q2 25 | $2.5B | $4.8B | ||
| Q1 25 | $1.8B | $4.7B | ||
| Q4 24 | $2.0B | $4.7B | ||
| Q3 24 | $2.1B | $4.7B | ||
| Q2 24 | $1.8B | $4.7B | ||
| Q1 24 | $1.2B | $4.7B |
负债/权益比INSMRBC
| Q4 25 | 0.74× | 0.30× | ||
| Q3 25 | 0.58× | 0.34× | ||
| Q2 25 | 0.44× | 0.29× | ||
| Q1 25 | 11.31× | 0.30× | ||
| Q4 24 | 3.93× | — | ||
| Q3 24 | 2.01× | — | ||
| Q2 24 | 30.66× | — | ||
| Q1 24 | — | 0.43× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-247.6M | $122.1M |
| 自由现金流经营现金流 - 资本支出 | $-264.2M | $99.1M |
| 自由现金流率自由现金流/营收 | -100.1% | 21.5% |
| 资本支出强度资本支出/营收 | 6.3% | 5.0% |
| 现金转化率经营现金流/净利润 | — | 1.81× |
| 过去12个月自由现金流最近4个季度 | $-967.6M | — |
8季度趋势，按日历期对齐
经营现金流INSMRBC
| Q4 25 | $-247.6M | $122.1M | ||
| Q3 25 | $-219.8M | $88.4M | ||
| Q2 25 | $-205.6M | $120.0M | ||
| Q1 25 | $-262.1M | — | ||
| Q4 24 | $-196.0M | $84.0M | ||
| Q3 24 | $-180.9M | — | ||
| Q2 24 | $-123.0M | $97.4M | ||
| Q1 24 | $-184.0M | — |
自由现金流INSMRBC
| Q4 25 | $-264.2M | $99.1M | ||
| Q3 25 | $-222.2M | $71.7M | ||
| Q2 25 | $-209.1M | $104.3M | ||
| Q1 25 | $-272.2M | — | ||
| Q4 24 | $-202.8M | $73.6M | ||
| Q3 24 | $-184.6M | — | ||
| Q2 24 | $-129.7M | $88.4M | ||
| Q1 24 | $-188.7M | — |
自由现金流率INSMRBC
| Q4 25 | -100.1% | 21.5% | ||
| Q3 25 | -156.1% | 15.7% | ||
| Q2 25 | -194.6% | 23.9% | ||
| Q1 25 | -293.2% | — | ||
| Q4 24 | -194.1% | 18.7% | ||
| Q3 24 | -197.6% | — | ||
| Q2 24 | -143.6% | 21.8% | ||
| Q1 24 | -250.0% | — |
资本支出强度INSMRBC
| Q4 25 | 6.3% | 5.0% | ||
| Q3 25 | 1.7% | 3.7% | ||
| Q2 25 | 3.2% | 3.6% | ||
| Q1 25 | 10.8% | 3.2% | ||
| Q4 24 | 6.5% | 2.6% | ||
| Q3 24 | 3.9% | 4.1% | ||
| Q2 24 | 7.5% | 2.2% | ||
| Q1 24 | 6.2% | — |
现金转化率INSMRBC
| Q4 25 | — | 1.81× | ||
| Q3 25 | — | 1.47× | ||
| Q2 25 | — | 1.75× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.45× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 1.59× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
INSM
暂无分部数据
RBC
| Domestic | $413.3M | 90% |
| Foreign | $48.3M | 10% |
